The Daily Newsletter of Market Infrastructure









LogoColorTextRight



Exchange Invest is a free daily email/web newsletter
about the core events pertaining to investment
in financial markets infrastructure such as:

  • exchanges
  • IT vendors
  • brokers
  • MTFs
  • clearing houses
  • etc.

Analyst Ratings

Exchange Invest maintains a listing of all recently published analysts ratings.

Note for analysts:

If your analysis is not included here, please Contact Us with your updates and we will be happy to include them.

Note for Companies & Investors:

This list is only an indication according to what has been publicly stated by the analysts, banks and brokers below and are reported by Exchange Invest in the interests of having a “consolidated tape” of analysts targets and weightings. We are not in any way responsible for creating these ratings nor can we be held accountable for them.

Exchanges

MTFs/Brokers/IDBs

IT Vendors

timthumb

 

Crowdfunding platforms

August 08 2016

ICE “Sector Perform” Restated By RBC Capital Markets – $282.00 Price Objective

August 05 2016

CME Upgraded By Zacks From “Hold” To “Buy” –  $116.00 Target Price

August 02 2016

LSE “Outperform” Rating Reiterated By BNP Paribas – GBX 2,700 Target Price

ICAP “Neutral” Rating Reaffirmed By BNP Paribas – GBX 450 Target Price

July 18 2016

Tullett Prebon “Buy” Rating Reiterated By Numis – 450 Target Price

July 13 2016

LSE “Outperform” Rating Restated By Credit Suisse – GBX 2,900 Price Target

July 05 2016

LSE “Outperform” Rating Restated By Credit Suisse –  GBX 2,900 Target Price

June 10 2016

CBOE Downgraded By Zacks From “hold” To “Sell” Rating

June 08 2016

LSE “Hold” Rating Reissued By Numis Securities – GBX 2,700 Target Price

May 11 2016

RBC Capital Initiated Coverage On ICE – “Sector Perform” Rating, $255.00 Price Target

May 10 2016

ICE Price Objective Lifted By Argus From $270.00 To $290.00 – “Buy” Rating

Deutsche Bank Assumed Coverage On ICE – “Buy” Rating, $295.00 Price Target

LSE “Outperform” Rating Reissued By BNP Paribas – GBX 2,750 Price Target

May 06 2016

Credit Suisse reiterated ‘Outperform’ On LSE – 2900 Target Price

Numis Reiterated ‘Hold’ On LSE – 2700 Target Price

April 27 2016

Exane BNP Paribas Set ‘Outperform’ Rating On LSE – Price Target 3,000

April 22 2016

LSE “Buy” Rating Reiterated By Citigroup

April 20 2016

Deutsche Bank Reissued “Buy” Rating On CME – $112.00 Target Price

NASDAQ OMX “Buy” Rating Restated By Deutsche Bank

Deutsche Bank Maintained “Hold” Rating On CBOE – Price Target Of $65

April 15 2016

Goldman Sachs Set ‘Neutral’ Rating On ICAP – GBX 520 Price Target

April 14 2016

Barclays Capital Maintained Nasdaq As ‘Overweight’ – $70 Price Target

April 11 2016

CBOE Stock Rating Noted As “Market Perform” By Keefe Bruyette & Woods –  $68.00 TP

March 18 2016

LSE Stock Rating Reiterated As ‘Outperform’ at Credit Suisse – 3,350 Target Price

March 17 2016

Macquarie Reaffirmed “Neutral” Rating On LSE – GBX 2,460 Price Objective

March 14 2016

Deutsche Bank Maintained “Buy” Rating On Nasdaq – $70 Price Target

March 10 2016

LSE “Outperform” Rating Reiterated By BNP Paribas – GBX 3,000 Target Price

LSE “Buy” Rating Restated By Citigroup

March 08 2016

Credit Suisse Raised Target Price For LSE To GBX 3,350 From GBX 2,900 – “Outperform” Rating

February 26 2016

Keefe, Bruyette & Woods Restated “Outperform” Rating On LSE – GBX 2,875 Target Price

BNP Paribas Reiterated “Outperform” Rating On LSE – GBX 2,930 Price Target

Numis Securities Restated “Hold” Rating On LSE – GBX 2,450 Price Target

February 18 2016

TMX Target Price Cut By TD Securities From C$46.00 To C$43.00 – “Hold” Rating

February 17 2016

ICE Price Objective Upped By Barclays From $286.00 To $287.00 – “Overweight” Rating

NASDAQ Price Target Increased By Barclays From $66.00 To $67.00 – “Overweight” Rating

February 12 2016

TMX Price Target Lowered By CIBC From C$58.50 To C$50.00 – “Sector Performer” Rating

February 11 2016

LSE “Outperform” Rating Reaffirmed By BNP Paribas – GBX 2,700 Target Price

February 10 2016

CBOE Price Target Increased By Deutsche Bank From $63.00 To $66.00

February 09 2016

Peter Lenardos from RBC Capital Reiterated A “Sell” On CME – $86 Price Target

RBC Capital on 5 February had ICE target price cut to $261.00 – “Sector Perform” Rating

February 03 2016

TMX Price Objective Lowered By Scotiabank From C$50.00 To C$48.00 – “Sector Perform” Rating

February 01 2016

NASDAQ OMX “Neutral” Rating Reaffirmed By Bank of America – $62.00 Target Price

January 28 2016

ICAP upgraded  from ‘neutral’ to ‘outperform’ by Credit Suisse – 510p price target maintained

CME “Buy” Rating Reaffirmed By Deutsche Bank – $105 Price Target

CBOE “Hold”Rating Reaffirmed By Deutsche Bank – $64 Price Target

CBOE Rating Lowered From “Buy” To “Hold” By Zacks Investment Research

January 27 2016

ICE Price Target Increased to $299.00 by Deutsche Bank – “Buy” Rating

NASDAQ OMX price objective increased from $65.00 to $66.00 by Deutsche Bank – “Buy” Rating

January 26 2016

Charles Schwab Upgraded From “Neutral” To “Buy” By Nomura

DB1 Rating Upgraded From “Sector Perform” To “Outperform” By RBC Capital Mkts

LSE “Outperform” Rating Reiterated By RBC Capital Markets + GBX 3,000 Price Target

IBKR downgraded from “buy” to “hold” by Zacks – $45.69 price target

January 25 2016

DB1 “Buy” Rating Issued By HSBC – 95.00 € Price Target

BNP Paribas Reiterated “Outperform” Rating for ICAP – GBX  590 Price Target

January 22 2016

LSE “Outperform” Rating Reiterated By Credit Suisse – GBX 2,900 Price Target

January 19 2016

Macquarie Reaffirmed “Neutral” Rating On LSE – GBX 2,468 Price Objective

January 15 2016

JPMorgan Chase Upgraded CME From “Neutral” To “Overweight” – $96.00 Price Target

NASDAQ OMX Target Price Boosted By Keefe, Bruyette & Woods From $60.00 To $61.00 – “Hold” Rating

CBOE Price Objective Cut By Keefe, Bruyette & Woods From $70.00 to $69.00 – “Hold” Rating

January 14 2016

NASDAQ OMX Price Objective Reduced By Barclays From $67.00 To $66.00 – “Overweight” Rating

January 13 2016

ICE Price Objective Increased By Deutsche Bank From $295.00 To $298.00 – “Buy” Rating

January 05 2016

CME Upgraded By Zacks From “Hold” To “Buy”, $101.00 Price Objective

December 15 2015

CME Price Target Hosited By Barclays From $98.00 To $99.00

NASDAQ OMX Price Objective Lifted By Barclays From $64.00 To $67.00 – “Overweight” Rating

December 10 2015

RBC Capital Began Coverage On ICE – “Sector Perform” Rating, $266.00 Price Target

TMX Downgraded By TD Securities From “Buy” To “Hold”

Nomura Upgraded Betfair To “Neutral” – GBX 3,450 Price Objective, Up From GBX 2,094

December 09 2015

RBC Capital Started Coverage On CME – “Underperform” Rating, $83.00 Price Target

NASDAQ Price Objective Lifted By Barclays From $64.00 To $67.00

CBOE Downgraded By Barclays From “Equal Weight” To “Underweight” – $59.00 Price Objective, Down From $61.00.

December 04 2015

LSE “Buy” Rating Reaffirmed By AlphaValue – Price Target Given GBX 3178.

November 27 2015

Credit Suisse Reaffirmed “Outperform” Rating On LSE – GBX 2,900 Price Objective

TMX Price Objective Lowered By Macquarie From C$44.00 To C$41.00 – “Neutral” Rating

November 25 2015

CBOE Price Objective Upped By Deutsche Bank From $64.00 To $65.00 – “Hold” Rating

Citigroup Upgraded ICAP To “Buy” – GBX 575 Target Price

November 24 2015

ICE Price Target Upped By Deutsche Bank From $293.00 To $295.00 – “Buy” Rating

November 13 2015

ICAP “Equal Weight” Rating Reiterated by Barclays – GBX 500 Price Objective
ICAP “Underwt/In-Line” Rating Reissued By Morgan Stanley – GBX 460 Price Objective
Bank of America Reissued “Neutral” Rating On ICAP GBX 500 Price Objective

November 12 2015

RBC Capital Reissued “Outperform” Rating On LSE

November 11 2015

ITG Upgraded By Zacks From “Sell” To “Hold”

November 10 2015

TMX Price Target Dropped By TD Securities From C$58.00 To C$56.00 – “Buy” Rating

November 05 2015

NASDAQ OMX Price Target Hoisted By Barclays From $62.00 To $64.00 – “Overweight” Rating

Barclays Restated “Underweight” Rating On Tullett Prebon – GBX 310 Target Price, Down From GBX 385

November 04 2015

Societe Generale Set A GBX 2,600 Price Target On LSE – “Neutral” Rating

November 03 2015

Argus Research Downgrades ICE To “Hold” From A “Buy” Rating

TMX Price Target Lowered By CIBC From C$61.00 To C$58.50 – “Sector Perform” Rating

ICAP Price Target Lifted By Numis Securities From GBX 370 To GBX 420 – “Hold” Rating

Barclays Restated “Outperform” Rating On ICAP – GBX 500 Target Price

Canaccord Genuity Reaffirmed “Sell” Rating On ICAP – GBX 350 Target Price

November 02 2015

ICE “Buy” Rating Reaffirmed By Deutsche Bank – $270.00 Price Objective, Down From $290.00

CME “Buy” Rating Reaffirmed By Deutsche Bank – $106.00 Price Target

October 30  2015

NASDAQ OMX Rating Lowered To “Market Perform” At Wells Fargo

Interactive Brokers Lowered To “Buy” At Vetr

October 29 2015

TMX C$49.00 Price Target At National Bank Financial

Societe Generale Reiterates GBX 2,600 Price Target For LSE

NASDAQ Downgraded From “Buy” To “Hold” By Vetr

October 28 2015

LSE Earns “Buy” Rating From Beaufort Securities

October 27 2015

LSE “Hold” Rating Kept By Numis

TMX Price Target Cut From C$50.00 To C$49.00 By National Bank Financial

 

October 26 2015

LSE “Overweight” Rating Reaffirmed By Barclays

Thomson Reuters “Sector Perform” Rating Reaffirmed At RBC Capital

TMX Price Objective Downgraded At RBC Capital Markets To $48.00

October 23 2015

TMX Price Target Cut By National Bank Financial From C$50.00 To C$49.00.

October 21 2015

LSE “Hold” Rating Reaffirmed By Numis Securities – GBX 2,450 Price Target

LSE “Hold” Rating Reaffirmed By HSBC – GBX 2,500 Price Target

CBOE Price Target Upped By Jefferies To $62.00 – “Hold” Rating

Thomson Reuters Price Target Raised By Scotiabank From C$55.00 To C$56.00 – “Sector Perform” Rating

October 20 2015

LSE “Outperform” Rating Reiterated By Credit Suisse – GBX 2,900 Price Target

NASDAQ OMX Price Objective Boosted To $53 By Jefferies – “Hold” Rating

October 19 2015

LSE “Overweight” Rating Reaffirmed By Barclays – GBX 2,840 Price Target
ICAP Downgraded By Barclays To “Equal Weight” – GBX 500 Price Objective, Down From GBX 600.

October 16 2015

Citigroup Reaffirmed “Buy” Rating On LSE – GBX 3,000 Target Price

October 13 2015

ICE “Buy” Rating Reiterated By Deutsche Bank
NASDAQ OMX Upgraded By Zacks From “Hold” To “Buy” – $59.00 Target Price

October 12 2015

LSE “Outperform” Rating Restated By RBC Capital
LSE “Buy” Rating Reaffirmed By Citigroup – GBX 3,000 Price Target
Deutsche Bank Maintained “Buy” Rating On CME – $107 Price Target

October 09 2015

Raymond James Raises Price Target For Nasdaq OMX To $61.00 From $60.00 – “Strong Buy” Rating
CBOE Target Price Hosited By KBW From $67.00 To $69.00 – “Market Perform” Rating

October 08 2015

CME Upgraded By BofA/Merrill To “Buy” From “Neutral”

October 02 2015

Lending Club “Sell” Rating Reiterated By Compass Point – $12.00 Price Objective

October 01 2015

Zacks Downgraded Thomson Reuters From “Hold” To “Sell”

September 29 2015

ICE “Buy” Rating Reiterated By Jefferies – $260.00 Price Target

September 25 2015

LSE “Neutral” Rating Reissued By Macquarie – GBX 2,468 Price Target

September 23 2015

NASDAQ OMX Upgraded By Zacks From “Hold” To “Buy” – $57.00 Price Objective
BNP Paribas Reaffirmed “Neutral” Rating On Betfair – GBX 3,000 Price Objective

September 18 2015

HSBC Reissued “Hold” Rating On LSE – GBX 2,500 Price Target

September 16 2015

RBC Capital Markets Reiterates “Outperform” Rating on LSE – GBX 2900 Target Price

September 10 2015

Keefe, Bruyette & Woods Increased Price Objective On CBOE From $65.00 To $67.00 – “Hold” Rating
Deutsche Bank Raised Price Target On NASDAQ OMX From $58.00 To $60.00
Deutsche Bank Reaffirmed “Hold” Rating On Betfair – GBX 2,650
Betfair “Neutral” Rating Reissued By BNP Paribas – GBX 3,000 Target Price

September 08 2015

CME Downgraded By Vetr From “Strong-Buy” To “Buy” – $104.72 Price Target
CBOE Upgraded By Zacks From “Hold” To “Buy” – $71.00 Price Target
Liberum Capital Reissued “Sell” Rating On ICAP – GBX 453 Price Objective

September 07 2015:

Barclays Cut Price Target On ICE From $274.00 To $273.00 – “Overweight” Rating.
CME “Neutral” Rating Reaffirmed By JPMorgan Chase – $97.00 Target Price, Down From $99.00.
CBOE “Neutral” Rating Restated By JPMorgan Chase – $55.00 Price Objective, Up From $50.00.

September 04 2015

Betfair “Reduce” Rating Reiterated At Numis Securities – GBX 2100 Target Price

September 03 2015

CBOE Reiterated By UBS To “Neutral” – Price Target Raised To $66 From $62

 

September 01 2015

CME Downgraded By Vetr From “Strong-Buy” To “Buy” – $104.72 Target Price

August 31 2015

Evercore ISI Lifted Price Objective On CME From $101.00 To $104.00 – “Buy” Rating

August 27 2015

Barclays Hoisted Price Target On CBOE From $56.00 To $57.00 – “Equal Weight” Rating
Barclays Raised Target Price On CME From $100.00 To $101.00 – “Equal Weight” Rating

August 26 2015

CBOE Upgraded By Zacks From “Hold” To “Buy” – $68.00 Target Price

August 25 2015

CME Upgraded By Vetr From “Buy” To “Strong-Buy” – $104.72 Price Target

August 21 2015

LSE “Outperform” Rating Restated By RBC Capital – GBX 2,900 Price Objective
LSE “Overweight” Rating Reissued By Barclays – GBX 2,840 Target Price
DB1 Upgraded By Zacks From “Sell” To “Hold”
CBOE Downgraded By Zacks From “Buy” To “Hold”

August 19 2015

AlphaValue Reaffirmed “Add” Rating On LSE – GBX 2,725 Price Objective

August 18 2015

CME “Buy” Rating Reiterated By Deutsche Bank – $108.00 Price Target

August 17 2015

DB1 Downgraded By Zacks From “Hold” To “Sell”

August 14 2015

Barclays Hoisted Price Objective On CME From $96.00 To $100.00 – “Equal Weight” Rating

August 13 2015

Morgan Stanley Lifted Target Price On Tullett Prebon From GBX 270 To GBX 433 – “Equal Weight” Rating

August 12 2015

Barclays Increased Their Target Price On ICE From $268.00 To $274.00 – “Overweight” Rating
Barclays Boosted Their “Price Objective” On NASDAQ OMX From $58.00 To $60.00 – “Overweight” Rating
Barclays Raised Their “Price Objective” On CBOE From $54.00 To $56.00 – “Equal Weight” Rating

August 10 2015

ICE “Buy” Rating Reiterated By Deutsche Bank – $256.00 Price Objective, Up From $252.00
CBOE “Hold” Rating Restated By Standpoint Research – $60.00 Target Price
ICE “Hold” RaFting Restated By Standpoint Research – $257.00 Price Target
NASDAQ OMX “Hold” Rating Reiterated By Standpoint Research – $58.00 Target Price
AlphaValue Reiterated Their “Add” Rating On LSE – GBX 2,788 Target Price
TD Securities Decreased Their Price Objective On TMX From C$62.00 To C$58.00 – “Buy” Rating
TMX Target Price Reduced By Scotiabank From C$56.00 To C$55.00

August 07 2015

LSE “Hold” Rating Reiterated By Numis Securities
Liberum Capital Reiterated Their “Sell” Rating On ICAP

August 06 2015

CBOE Upgraded By Zacks From “Hold” To “Buy” – $70.00 Price Target
LSE “Outperform” Rating Reiterated By RBC Capital – GBX 2,900 Price Objective

August 05 2015

Liberum Reconfirms A “Hold” Rating On Tullett Prebon – GBX 362 Target Price

August 04 2015

UBS Maintains CBOE To “Neutral” – Price Target $62.00

August 03 2015

CME “Buy” Rating Reissued By Deutsche Bank – $107.00 Price Target
CME “Hold” Rating Reaffirmed By Keefe, Bruyette & Woods – $102.00 Price Objective

July 31 2015

Deutsche Bank Reaffirmed Their “Buy” Rating On Charles Schwab – $42.00 Target Price

July 30 2015

Credit Suisse Reiterated Their “Outperform” Rating On LSE

July 24 2015

AlphaValue Reissued Their “Add” Rating On LSE – GBX 2,796 Target Price

July 21 2015

LSE Price Target Increased By RBC Capital From GBX 2,700 To GBX 2,900 – “Outperform” Rating

July 20 2015

Evercore ISI Upped Their Price Target On CME From $101.00 To $102.00 – “Buy”Rating

July 16 2015

ICAP “Neutral” Rating Reaffirmed By Credit Suisse – GBX 550 Price Target

July 14 2015

Barclays Reiterated Their “Overweight” Rating On LSE

July 13 2015

Barclays Boosted Their Price Target On ICE From $260.00 To $267.00 –  “Overweight” Rating

CME Target Price Boosted By Barclays From $87.00 To $96.00 – “Equal Weight” Rating

July 10 2015

Zacks Upgraded CME From “Hold” To “Buy” – $106.00 Price Objective

CME Upgraded By Vetr From “Strong Sell” To “Buy” – $103.08 Price Objective

July 08 2015

LSE “Overweight” Rating Reconfirmed At Barclays Capital –  GBX 2780.00 Target Price

Barclays Decreased Their Price Objective On ICAP To GBX 600 –  “Overweight” Rating

July 06 2015

Goldman Sachs Cut Its Recommendation ON HKEx To “Sell” From “Neutral”

July 03 2015

NASDAQ OMX “Overweight” Rating Restated By Barclays – $57.00 Price Objective

Deutsche Bank Raised Their Price Target On CBOE From $55.00 To $58.00 – “Hold” Rating

July 02 2015

Keefe, Bruyette & Woods Hoisted Their Target Price On CME From $98.00 To $100.00

Keefe, Bruyette & Woods Lowered NASDAQ OMX From “Outperform” To “Market Perform” – $55.00 Price Objective

Tullett Prebon Downgraded By Canaccord Genuity To “Hold” – GBX 375 Target Price

June 29 2015

Zacks Upgraded ICE From “Sell” To “Hold”

NASDAQ OMX “Buy” Rating Reissued By Deutsche Bank – $56.00 Price Objective, Down From $57.00

June 26 2015

LSE “Outperform” Rating Restated By RBC Capital

LSE “Hold” Rating Restated By Numis Securities – GBX 2,300 Target Price

June 19 2015

ICAP “Overweight” Rating Reissued By Barclays – GBX 625 Price Objective

Macquarie Reiterated Their “Neutral” Rating On ICAP – GBX 538 Price Objective

June 18 2015

Keefe, Bruyette & Woods Increased Their Price Objective On CME From $92.00 To $98.00 – “Market Perform” Rating

Keefe, Bruyette & Woods Reduced Their Price Target On ITG To $32.00 – “Outperform” Rating

June 16 2015

TMX Upgraded To “Buy” From “Hold” By TD Securities – Price Target To $62 From $57

June 11 2015

Stifel Upgraded LendingClub From “Hold” To “Buy” – $25 Price Target

LendingClub Upgraded By KeyBanc Capital Markets To “Overweight” From “Sector Weight” –  $23 Price Target

June 10 2015

ICE Was Downgraded By Zacks From “Hold” To “Sell” Rating

RBC Capital Raised Their Target Price On LSE From GBX 2,600 To GBX 2,700 – “Outperform” Rating

CBOE Upgraded By Evercore ISI from “Sell” To “Hold” – $55.00 Price Target

June 09 2015

CBOE Upgraded By Keefe, Bruyette & Woods To “Market Perform”

Goldman Sachs Upgraded Its Rating On Charles Schwab To “Buy”

Piper Jaffray Initiated Coverage on Charles Schwab – $39.00 Price Target, “Overweight” Rating

June 08 2015

JPMorgan Chase Dropped Their Price Target On ICE From $264.00 To $252.00 – “Overweight” Rating

JPMorgan Chase Dropped Their Price Objective On CME From $93.00 To $92.00 – “Neutral” Rating

JPMorgan Chase Reduced Their Price Objective On CBOE From $55.00 To $50.00 – “Neutral” Rating

Numis Cut Betfair To “Sell” – GBX 2,100 Price Target

June 05 2015

Scotiabank Reissued Their “Sector Perform” Rating On TMX

Tullett Prebon Price Objective Raised By Citigroup From GBX 300 To GBX 390 – “Neutral” Rating

June 03 2015


LSE “Outperform” Rating Reiterated By Credit Suisse – GBX 2,900 Price Objective

May 29 2015

NASDAQ OMX Given “Hold” Rating By Jefferies Group – $50 Target Price

ICAP Downgraded To “Sell” By Numis – GBX 440 Target Price

May 28 2015


LSE Given “Buy” Rating at Citigroup – GBX 3,000 Price Target

May 26 2015


LSE “Buy” Rating Reaffirmed By Bank of America

May 25 2015

HSBC Reaffirms “Hold” Rating For LSE – GBX 2,700 Price Target

CBOE Holdings Price Target Lowered To $48.00 By Barclays – “Equal Weight” Rating

May 22 2015

LSE “Overweight” Rating Reiterated By Barclays Capital

RBC Capital Restated Their “Outperform” Rating On LSE

LSE “Add” Rating Restated By AlphaValue – GBX 2,801 Target Price

ICAP Earned “Hold” Rating from Shore Capital

Tullett Prebon Earned “Buy” Rating from Canaccord Genuity

May 20 2015

Credit Suisse Reaffirmed Their “Neutral” Rating On ICAP – GBX 550 Price Target

Canaccord Genuity Reissued Their “Buy” Rating On Tullett Prebon – GBX 330 Price Objectiv

May 14 2015

TMX Downgraded By National Bank Financial From “Sector Perform” To “Underperform” – C$50.00 Price Target, Down From C$56.00

May 13 2015

HSBC Reiterated Their “Reduce” Rating On ICAP – GBX 480 Price Objective

May 12 2015

Deutsche Bank Restated Their “Buy” Rating On CME – $105.00 Target Price

 

May 11 2015

CME Upgraded By Evercore Partners From “Hold” To “Buy”

Barclays Decreased Their Price Target On ICE From $267.00 To $261.00 –  “Overweight” Rating

NASDAQ OMX Target Price Boosted By Barclays From $56.00 To $57.00 – “Overweight” Rating

May 08 2015

LSE “Add” Rating Reaffirmed By AlphaValue – GBX 2,758 Price Objective

ICAP “Neutral” Rating Reissued By JPMorgan Chase – GBX 525 Price Target

May 05 2015

CBOE Price Target Cut By Barclays From $49.00 To $48.00 – “Equal Weight” Rating

May 04 2015

CME Price Objective Cut By Barclays From $90.00 To $89.00 – “Equal Weight” Rating

CME “Buy” Rating Reissued By Deutsche Bank – $104.00 Target Price

Barclays Restated Their Overweight Rating On LSE – GBX 2,700 Target Price

April 30 2015

LSE “Outperform” Rating Reaffirmed By RBC Capital – GBX 2,600 Price Objective

April 29 2015

CME “Hold” Rating Restated By Credit Suisse – $95.00 Price Target

LSE “Outperform” Rating Reiterated By Credit Suisse – GBX 2,900 Price Objective

April 27 2015

NASDAQ OMX “Overweight” Rating Restated By Barclays – $56.00 Price Objective, Up From $55.00

TD Securities Hoisted Their Target Price On TMX From C$53.00 To C$57.00 – “Hold” Rating

April 24 2015

LSE “Add” Rating Reissued By AlphaValue – GBX 2,817 Price Target

 

April 23 2015

Macquarie Cut LSE To “Neutral” – GBX 2,466 Price Target

ICAP “Neutral” Rating Restated By Macquarie – GBX 488 Price Target

ICAP “Sell” Rating Reissued By Liberum Capital – GBX 405 Price Target

April 22 2015

HSBC Cut DB1 To A “Hold” Rating

April 17 2015

National Bank Financial Increased Their Price Target On TMX From C$52.00 To C$56.00 – “Sector Perform” Rating

April 16 2015

ICAP Price Target Upped By Barclays From GBX 500 To GBX 600 – “Overweight” Rating

 

April 15 2015

ICAP “Hold” Rating Reiterated By Shore Capital

 

April 09 2015

LSE “Outperform” Rating Reiterated By Credit Suisse – GBX 2,900, up from GBX 2,350

 

April 08 2015

ICE Target Price Boosted By Jefferies Group From $250.00 To $260.00 – “Buy” Rating

ICAP Upgraded By Credit Suisse Group To “Neutral” Rating

April 07 2015

LSE “Sell” Rating Reissued By AlphaValue – GBX 2,214 Price Target

Raymond James Lifted Their Price Objective On CBOE From $63.00 To $65.00 – “Outperform” Rating

Credit Suisse Set A $58.00 Price Target On CBOE – “Sell” Rating

April 02 2015

LSE “Hold” Rating Reissued By Numis Securities – GBX 2,300 Target Price

April 01 2015

RBC Capital Reissued Their “Outperform” Rating On LSE – GBX 2,600 Price Objective

March 31 2015

Jefferies Increased Their “Price Objective” On CME To $104.00

ITG Upgraded By Evercore Partners From “Hold” To “Buy” – $33.00 Price Objective, Up From $24.00

March 27 2015

CME “Buy” Rating Reaffirmed By Zacks – $106.00 Price Target

CBOE “Sell” Rating Reiterated By Citigroup – $52.00 Target Price, Down From $54.00

Numis Securities Hoisted Their Price Objective On Tullett Prebon From GBX 360 To GBX 420 – “Add” Rating

March 20 2015

Deutsche Bank Reiterated Their “Hold” Rating On ICE – $250.00 Price

Deutsche Bank Reiterated Their “Buy” Rating On NASDAQ OMX – $67.00 Price Objective

Deutsche Bank Restated Their “Hold” Rating On CBOE – $60.00 Target Price

AlphaValue Restated Their “Sell” Rating On LSE – GBX 2,174 Price Objective

March 19 2015

NASDAQ OMX Target Price Lifted By Keefe, Bruyette & Woods From $55.00 To $57.00 – “Outperform” Rating

March 18 2015

Charles Schwab Upgraded By JMP Securities From “Market Perform” To “Outperform”

March 11 2015

ICE “Neutral” Rating Reaffirmed by Zacks – $246.00 Price Objective

LSE “Neutral” Rating Reiterated By HSBC – GBX 2,570 Target Price

Scotiabank Increased Their Price Objective On TMX From C$51.00 To C$56.00 – “Sector Perform” Rating

March 10 2015

Barclays Reduced Their Price Target On NASDAQ OMX From $56.00 To $55.00 – “Overweight” Rating

March 09 2015

ICE “Hold” Rating Reiterated By Deutsche Bank – $250.00 Target Price on the stock, up from $247.00

CME Price Target Increased By Deutsche Bank From $104.00 To $106.00 – “Buy” Rating

CBOE “Hold” Rating Reiterated By Deutsche Bank – $60.00 Price Target, Down From $64.00

March 06 2015

LSE “Outperform” Rating Restated By Credit Suisse – GBX 2,350 Price Target

March 04 2015

Credit Suisse Restated Their “Underperform” Rating On CBOE – $58.00 Target Price

CBOE Price Target Decreased By Barclays From $54.00 To $53.00 – “Equal Weight” Rating

Numis Reaffirmed Their “Add” Rating On Tullett Prebon – GBX 360 Price Objective

Liberum Capital Restated Their “Sell” Rating On Tullett Prebon – GBX 274 Price Objective

March 03 2015

LSE “Sell” Rating Reiterated At AlphaValue – GBX 2,129 Price Objective

CBOE Downgraded By Bank of America From “Buy” To “Neutral” Rating – $63.00 Price Target

March 02 2015

Compass Point Reduced Their Price Target On Lending Club From $19.00 To $16.00 – “Sell” Rating

February 23 2015

Barclays Upped Their Target Price On ICE From $256.00 To $268.00 – “Overweight” Rating

NASDAQ OMX Price Target Upped By Barclays From $55.00 To $56.00 – “Overweight” Rating

February 20 2015

LSE “Neutral” Rating Reiterated By Goldman Sachs – GBX 2,640 Target Price

February 19 2015

Credit Suisse Set A $95.00 Target Price On CME – “Hold” Rating

February 17 2015

Argus Upped Their Price Objective On ICE From $240.00 To $262.00 – “Buy” Rating

February 12 2015

Betfair “Hold” Rating Reiterated By Deutsche Bank – GBX 1,499 Price Target

February 11 2015

Argus Lifted Their Target Price On CME From $95.00 To $106.00 –  “Buy” Rating

ICE Price Target Upped By Barclays From $253.00 To $256.00 – “Overweight” Rating

February 10 2015

CME “Neutral” Rating Reaffirmed By Zacks – $99.00 Price Target

ICE “Neutral” Rating Restated By Zacks – $237.00 Price Target

Deutsche Bank Reiterates Its “Hold” On CBOE – Price Target Reduced To $64 From $69

CBOE “Hold” Rating Reiterated By JPMorgan Chase – $56.00 Target Price, Down From $57.00

Citigroup Reaffirmed Their “Underweight” Rating On CBOE

Liberum Capital Lowered Their Price Objective On ICAP From GBX 408 To GBX 405 – “Hold” Rating

February 09 2015

CME Price Target Upped By Citigroup From $94.00 To $100.00 – “Buy” Rating

ICE Price Objective Raised By Deutsche Bank From $235.00 To $247.00 – “Hold” Rating

ICE Price Objective Raised By Barclays From $253.00 To $256.00 – “Overweight” Rating

RBC Capital Lowered Their Price Target On TMX From C$54.00 To C$48.00 – “Underperform” Rating

February 03 2015

ICE Target Price Lifted By JPMorgan Chase From $265.00 To $269.00 – “Overweight” Rating

Credit Suisse Decreased Their Price Objective On NASDAQ OMX From $57.00 To $55.00

Keefe, Bruyette & Woods Hoisted Their Price Target On ITG From $23.00 To $24.00 – “Outperform” Rating

January 29 2015

TMX Price Objective Lowered By Scotiabank From C$60.00 To C$53.00 – “Sector Perform” Rating

January 27 2015

LSE Target Price Lifted By RBC Capital From GBX 2,150 To GBX 2,500 – “Outperform” Rating

Betfair “Overweight” Rating Reissued By HSBC – GBX 1,942.86 Price Target

January 26 2015

CME Target Price Boosted By Deutsche Bank From $101.00 To $102.00 – “Buy” Rating

National Bank Financial Dropped Their Price Objective On TMX from C$57.00 To C$56.00 – “Sector Perform” Rating

January 21 2015

ICE Downgraded By Zacks From “Outperform” To “Neutral” – $220.00 Price Target

Citigroup Upgraded CME From “Neutral” To “Buy rating-  $86.00 price objective

January 20 2015

ITG Upgraded By Zacks From “Neutral” To “Outperform” – $21.40 Price Target

Charles Schwab “Buy” Rating Reaffirmed By Deutsche Bank – $37.00 Price Target

Zacks Restated Their “Neutral” Rating On Charles Schwab – $28.50 Price Objective

January 15 2015

LSE “Neutral” Rating Reiterated By JPMorgan Chase – GBX 2,330 Target Price

Goldman Sachs Lowered CBOE From “Neutral” to “Sell” Rating – $56.00 Price Objective

January 14 2015

Barclays Lifted Their Price Objective On ICE From $244.00 To $250.00 – “Overweight” Rating

NASDAQ OMX Price Objective Raised By Barclays From $50.00 To $54.00 – “Overweight” Rating

LSE “Overweight” Rating Reaffirmed By Barclays – GBX 2,550 Price Target

TMX Target Price Cut By RBC Capital From C$55.00 To C$54.00 – “Underperform” Rating

January 13 2015

Keefe, Bruyette & Woods Raised Their Target Price On CBOE From $59.00 To $62.00 – “Market Perform” Rating

January 09 2015

CME Downgraded By Credit Agricole From “Outperform” To “Underperform”

Credit Suisse Reissued Their “Outperform” Rating On LSE – GBX 2,350 Price Objective

January 08 2015

ICE Price Objective Raised By Credit Suisse From $225.00 To $245.00 – “Outperform” Rating

CME Target Price Lifted By Jefferies Group From $93.00 To $97.00 – “Buy” Rating

Citigroup Reiterated Their “Buy” Rating On NASDAQ OMX – $56.00 Price Objective

CBOE Price Target Increased By Jefferies Group From $54.00 To $61.00 – “Hold” Rating

January 07 2015

Credit Suisse Raised Their Target Price On CBOE From $56.00 To $63.00 – “Underperform” Rating

December 23 2014

Keefe, Bruyette & Woods Set A $32.00 Target Price On Interactive Brokers – “Buy” Rating

Lending Club Earns “Hold” Rating From Rafferty Capital Markets

December 19 2014

CME “Neutral” Rating Reissued By Zacks – $94.00 Price Objective

LSE “Buy” Rating Restated By Espirito Santo Investment Bank – GBX 2,364 Target Price

RBC Capital Restated Their “Outperform” Rating On LSE – GBX 2,150 Price Target

December 18 2014

Numis Securities Reiterated Their “Hold” Rating On LSE – GBX 2,074 Target Price

ASX Had Its Price Objective Raised By RBC Capital From $5.50 To $6.25 – Outperform Rating

Lending Club Had Its Price Target Upped By BTIG Research To $31.00

December 16 2014

RBC Capital Markets Initiated A Coverage On Euronext NV – “Outperform” Rating, €30 Price Target

Deutsche Bank Lifted Their Price Objective On Charles Schwab From $35.00 To $36.00 – “Buy” Rating

December 15 2014

ICE Target Price Boosted By Deutsche Bank From $230.00 To $238.00 – “Hold” Rating

CME Target Price Boosted By Deutsche Bank From $96.00 To $98.00 – “Buy” Rating

NASDAQ OMX Target Price Boosted By Deutsche Bank From $49.00 To $52.00 – “Buy” Rating

LSE “Neutral” Rating Reissued By HSBC – GBX 2,280 Price Objective

CBOE Price Objective Raised By Deutsche Bank From $65.00 To $66.00 – “Hold” Rating

December 11 2014

CME Had Its Price Objective Hosited By Argus From $92.00 To $95.00 – “Buy” Rating

December 09 2014

Keefe Bruyette & Woods Upgraded NASDAQ OMX From “Market Perform” To “Outperform” – Price Target Raised From $45 To $55

CME Downgraded By Keefe, Bruyette & Woods From “Outperform” To “Market Perform” – $92.00 Price Target

December 08 2014

JPMorgan Chase Restated Their “Neutral” Rating On LSE – GBX 2,330 Price Objective

December 05 2014

Credit Suisse Boosted Their Price Target On ICE From $220.00 To $225.00 – “Outperform” Rating

Barclays Reaffirmed Their “Overweight’ Rating On ICAP – GBX 465 Price Objective

Tullett Prebon “Overweight” Rating Restated By HSBC – GBX 320 Price Target

December 03 2014

Barclays Hoisted Their Price Objective On CBOE From $48.00 To $52.00 –  “Equal Weight” Rating

December 02 2014

ICE Was Upgraded By Zacks From “Neutral” To “Outperform” – $265.00 Target Price

Zacks Reaffirmed Their “Neutral” Rating On Charles Schwab – $30.00 Price Target

November 27 2014

Zacks Reissued Their “Neutral” Rating On NASDAQ OMX – $47.00 Price Target

November 26 2014

DB1 Upgraded By Citigroup From “Neutral” To “Buy”

November 25 2014 

LSE Upgraded By Citigroup To “Buy” – GBX 2,400 Target Price, Up From GBX 1,750

November 21 2014

AlphaValue Reiterated Their “Sell” Rating On LSE – GBX 1,702 Price Objective

Numis Securities Reaffirmed Their “Hold’ Rating On ICAP – GBX 370 Target Price

ICAP “Sell” Rating Restated By Espirito Santo Investment Bank Research – GBX 317 Price Target

November 19 2014

Morgan Stanley Boosted Their Price Objective On LSE From GBX 2,210 To GBX 2,280 – “Overweight” Rating

November 17 2014

LSE “Outperform” Rating Reaffirmed By Credit Suisse –  GBX 2,350 Target Price

LSE “Buy” Rating Reaffirmed By Espirito Santo Investment Bank Research – GBX 2,303 Price Target

November 13 2014

Evercore Partners Downgraded CBOE From “Hold” To “Sell” – $55.00 Target Price

Betfair Upgraded By Goodbody Stockbrokers To “Buy” – GBX 1,450 Target Price

November 12 2014

Zacks Upgraded Shares Of CBOE To “Neutral’ – $65.00 Price Objective

JPMorgan Chase Upgraded Betfair To “Overweight” Rating – GBX 1,350 Target Price, Up From GBX 1,175

November 11 2014

National Bank Financial Dropped Their Target Price On TMX From C$58.00 To C$57.00 – “Sector Perform” Rating

November 10 2014

Keefe, Bruyette & Woods Set A $245.00 Price Objective On ICE – Outperform Rating

November 07 2014

ICE Downgraded At Deutsche Bank To “Hold” From “Buy” – Price Target Raised To $230 From $220.

November 06 2014

Zacks Reissued Their “Neutral” Rating On ICE –  $228.00 Price Target

Numis Securities Reiterated Their “Hold” Rating On LSE – GBX 2,074 ($33.06) Target Price

Keefe, Bruyette & Woods Reiterated Their “Outperform’ Rating On ITG – $23.00 Target Price, Up From $22.00

November 04 2014

DB1 Upgraded By RBC Capital Markets To “Sector Perform” –  €59 Price Target, Up From €56

CBOE “Neutral” Rating Restated By Citigroup – $57.00 Price Target, Up From $55.00

Keefe, Bruyette & Woods Reissued Their “Market Perform” Rating On CBOE – $59.00 Target Price, Up From $57.00.

CBOE “Neutral” Rating Reaffirmed By JPMorgan Chase, $56.00 Price Target on the stock, up From $55.00

November 03 2014

Betfair “Hold” Rating Restated By Deutsche Bank – GBX 1,160 Price Target

Shore Capital Reissued Their “Sell” Rating On Tullett Prebon

October 29 2014

Credit Suisse Reaffirmed Their “Outperform” Rating On NASDAQ OMX – $44.00 Price Target, Down From $45.00

Morgan Stanley Lifted Their Target Price On LSE From GBX 2,098 To GBX 2,210 – “Overweight” Rating

RBC Capital Lowered Their Target Price On TMX From C$57.00 To C$56.00 – “Underperform” Rating

Morgan Stanley Raised Their Price Objective On ICAP From GBX 386 To GBX 408 – “Equal Weight” Rating

Deutsche Bank Reaffirmed Their “Buy” Rating On Charles Schwab – $35.00 Price Target

October 28 2014

Barclays Reaffirmed Their “Overweight” Rating On NASDAQ OMX – $47.00 Price Objective, Down From $48.00

October 24 2014

HSBC Upgraded LSE To “Overweight’ – GBX 2,100 Price Objective

October 20 2014

Compass Point Reaffirmed Their Neutral Rating On Charles Schwab – $26.00 Price Target, Down From $28.00

October 14 2014

ICE Upgraded By Zacks From “Underperform” To “Neutral” – $213.00 Target Price

CME Downgraded By Wells Fargo From “Outperform” To “Market Perform” – $75.00 Price Objective, Down From $85.00

October 10 2014

Bank of America Reaffirmed Their “Neutral” Rating On CME – $82.00 Target Price, Up From $76.00

LSE “Market Perform” Rating Reaffirmed By BMO Capital Markets – GBX 1,800 Target Price

Interactive Brokers “Outperform” Rating Reaffirmed By Keefe, Bruyette & Woods – $29.00 Price Target, Up From $27.00

October 09 2014

CME “Neutral” Rating Reiterated By Deutsche Bank – $82.00 Price Objective, Up From $76.00

Zacks Restated Their “Neutral” Rating On Interactive Brokers – $26.00 Price Objective

October 08 2014

ICE Upgraded By Citigroup From “Neutral” To “Buy”

Citigroup Assumed Coverage On CBOE – $55.00 Price Target

CME “Neutral” Rating Reaffirmed By Citigroup – $82.00 Target Price Up From $73.00

GFI Upgraded By Zacks From “Underperform” To “Neutral” – $5.50 Price Target

October 07 2014

ICAP “Underperform” Rating Reissued By Credit Suisse – GBX 370 Target Price

October 06 2014

ICAP “Sell” Rating Reaffirmed By Liberum Capital – GBX 306 ($4.97) Price Objective

Liberum Capital Restated Their Sell Rating On Tullett Prebon – GBX 240 Target Price

October 03 2014

Deutsche Bank Upgraded ICE From “Hold” To “Buy” –  $219.00 Target Price Up From $202.00

Credit Suisse Reiterated Their “Underperform” Rating On CBOE – $53.00 Price Objective, Up From $49.00

Deutsche Bank Upgraded Nasdaq OMX From “Hold” to “Buy” – $49.00 Target Price, Up From $46.00

October 02 2014

LSE “Outperform” Rating Restated By RBC Capital – GBX 2,150 ($34.93) Price Target

October 01 2014

ICAP “Hold” Rating Restated By Societe Generale – GBX 360 Target Price

Espirito Santo Investment Bank Research Reiterated Their Sell Rating On ICAP – GBX 312 Price Objective

September 30 2014

Numis Securities Restated Their “Sell” Rating On ICAP – GBX 303 Target Price

September 29 2014

JPMorgan Chase Raised Their Price Target On Betfair From GBX 1,050 To GBX 1,175 – “Neutral” Rating

September 26 2014

BMO Capital Markets Initiated Coverage On GFI Group – “Outperform” Rating And $4.25 Target Price

September 25 2014

BMO Capital Markets Assumed Coverage On TMX  – “Market Perform” Rating

September 19 2014

ICE “Outperform” Rating Reaffirmed By Keefe, Bruyette & Woods – $225.00 Price Target

CME “Outperform” Rating Reiterated By Keefe, Bruyette & Woods – $90.00 Price Objective

AlphaValue Reiterated Their Reduce Rating On LSE – GBX 1,783 Price Target

Credit Suisse Upped Their Price Target On Betfair From GBX 1,085 To GBX 1,200 – “Neutral” Rating

September 18 2014

Argus Hoisted Their Price Objective On CME From $84.00 To $92.00 – “Buy” Rating

September 17 2014

NASDAQ OMX “Neutral” Rating Reaffirmed By Zacks – $46.00 Price Objective

September 15 2014

Macquarie Reissued Their Neutral Rating On LSE – GBX 1,960.20 Price Target

September 12 2014

Numis Securities Assumed Coverage On LSE –  “Hold” Rating, GBX 2,074 Price Target

September 11 2014

CBOE “Buy” Rating Reaffirmed By Deutsche Bank – $63.00 Price Target

ICE “Hold” Rating Restated By Deutsche Bank

LSE “Outperform” Rating Restated By RBC Capital – GBX 2,200 Price Target

CME “Buy” Rating Reiterated By Deutsche Bank – $85.00 Target Price.

September 03 2014

Charles Schwab Corp “Neutral” Rating Restated By Zacks – $30.00 Price Objective

August 28 2014

ICAP “Sell” Rating Restated by Liberum Capital – GBX 306 Price Objective

Tullett Prebon “Sell” Rating Restated By Liberum Capital – GBX 219 Price Objective.

August 27 2014

LSE “Hold” Rating Restated By Beaufort Securities.

August 26 2014

CBOE Upgraded By Raymond James To “Outperform”.

August 25 2014

RBC Capital Reissued Their “Outperform” Rating On LSE – GBX 2,200 Price Objective.

LSE “Under Review” Rating Reaffirmed By Numis Securities Ltd.

LSE “Buy” Rating Reiterated By Espirito Santo Investment Bank – GBX 2,364 Target Price.

August 21 2014

SGX “Buy” Rating Initiated By Jefferies – S$8.00 Price Target, Up From S$7.27

August 18 2014

Markit “Buy” Rating Reiterated By Deutsche Bank – $30.00 Price Objective

August 12 2014

Zacks Restated Their “Underperform” Rating On ICE – $171.00 Target Price

JPMorgan Chase Reaffirmed Their “Overweight” Rating On ICE – $223.00 Target Price, Down From $230.00.

Keefe, Bruyette & Woods Reiterated Their “Outperform” Rating On ICE – $223.00 Target Price, Down From $232.00.

TD Securities Lowered Price Objective On TMX From C$59.00 To C$57.00 – “Hold” Rating

Zacks Lowered CBOE From “Neutral To “Underperform” – $46.00 Price Objective

August 11 2014

TMX “Sector Perform” Rating Reiterated By Scotiabank – C$62.00 Price Objective

August 07 2014

TMX “Sector Perform” Rating Restated By National Bank Financial – C$63.00 Price Target on the stock, Up From C$60.00.

August 04 2014

Sandler O’Neill Lowered GFI Group From “Buy” To “Hold” – $4.55 Price Objective
CME “Equal Weight” Rating Restated By Barclays – $75.00 Price Objective
CME ““Neutral” Rating Reaffirmed By Zacks – $78.00 Price Target
TMX Upgraded By BMO Capital Markets To “Outperform”

July 31 2014

Betfair Downgraded By Nomura To “Reduce” – GBX 923 Target Price

July 28 2014

NASDAQ OMX “Outperform” Rating Restated By Credit Suisse – $45.00 Target Price, Up From $42.00

NASDAQ OMX “Overweight” Rating Restated By Barclays – $44.00 Price Objective, Up From $42.00

NASDAQ OMX “Neutral” Rating Reiterated By Zacks – $44.00 Price Target

NASDAQ OMX “Buy” Rating Reiterated By Citigroup – $50.00 Target Price, Up From $45.00

RBC Capital Markets Downgraded DB1 To “Underperform”

July 25 2014

ICE “Overweight” Rating Reaffirmed By JPMorgan Chase – $230.00 Price Target, Down From $233.00

July 21 2014

ICE Downgraded By Zacks From “Neutral” To “Underperform” – $174.00 Target Price

LSE “Outperform” Rating Restated By Credit Suisse – GBX 2,350 Price Target

Citigroup Decreased Their Target Price On ICAP From GBX 385 To GBX 370 – “Neutral” Rating

July 18 2014

Numis Securities Reissued Their “Add” Rating On LSE

 

July 17 2014

LSE “Hold” Rating Reaffirmed By Societe Generale – GBX 2,160 Target Price

Tullett Prebon “Neutral” Rating Reiterated By Macquarie – GBX 231 Price Objective

July 16 2014

Evercore Partners Upgraded Shares Of NASDAQ OMX From “Equal Weight” To “Overweight” – $46.00 Price Objective

July 15 2014

CME Upgraded By Zacks From “Underperform” To “Neutral” – $74.00 Price Target

 

July 14 2014

Keefe, Bruyette & Woods Lifted Their Price Objective On NASDAQ OMX From $40.00 To $45.00

Keefe, Bruyette & Woods Hoisted Their Price Objective On Interactive Brokers From $26.00 To $27.00

July 11 2014

LSE “Buy” Rating Reaffirmed By Espirito Santo Investment Bank Research GBX 2,364 Price Target

LSE “Outperform” Rating Reiterated By RBC Capital – GBX 2,200 Price Target

July 10 2014

 

Interactive Brokers Downgraded By Zacks From “Outperform” To “Neutral” Rating – $24.50 Price Objective

July 09 2014

ICE “Overweight” Rating Reaffirmed By JPMorgan Chase – $230.00 Price Objective

JPMorgan Chase Lifted Their Price Target On CME From $67.50 To $68.00

JPMorgan Chase Reduced Their Price Objective On CBOE From $49.00 To $48.50

July 08 2014 

LSE “Outperform” Rating Reaffirmed By Credit Suisse – GBX 2,350 Target Price

Zacks Reissued Their “Neutral” Rating On CBOE –  $51.00 Target Price

Charles Schwab Upgraded By Raymond James From “Underperform” To “Market Perform”

July 01 2014

ICE “Overweight” Rating Restated By Barclays – $212.00 Target Price

LSE “Add” Rating Restated By Numis Securities

Barclays Increased Their Price Target On CME From $75.00 To $77.00 – “Equal Weight” Rating

 

June 30 2014

Credit Suisse Upped Their Price Objective On LSE From GBX 2,220 To GBX 2,350 – “Outperform” Rating

June 25 2014

ICE Downgraded By Wells Fargo To “Market Perform”

Betfair “Neutral” Rating Restated By Credit Suisse – GBX 1,085 Target Price

ITG Downgraded By JPMorgan Chase & Co. To “Neutral” – $19.00 Price Objective

June 19 2014

LSE Receives “Overweight” Rating From Morgan Stanley

June 11 2014

ICE “Overweight” Rating Reaffirmed By JPMorgan Chase – $224.00 Price Target

JPMorgan Chase & Co. Cut Their Price Objective On CME From $69.50 To $67.50

CBOE “Neutral” Rating Reaffirmed By JPMorgan Chase –  $49.00 Price Target

ITG “Overweight” Rating Reaffirmed By JPMorgan Chase – $23.00 Target Price

June 10 2014

CME Downgraded By Zacks From “Neutral” To “Underperform” –  $63.00 Price Objective

Barclays Reissued Their “Overweight” Rating On NASDAQ – $43.00 Price Target

June 09 2014

Credit Suisse Restated Their Outperform Rating On ICE –  $215.00 Target Price

LSE “Neutral” Rating Reaffirmed By Macquarie – GBX 2,128 Price Target

June 06 2014

ICE “Overweight” Rating Restated By Barclays – $225.00 Price Target

CBOE “Equal Weight” Rating Restated By Barclays – $46.00 Price Target

Barclays Restated Their “Overweight” Rating On ICAP – GBX 450 Target Price

June 05 2014

Tullett Prebon “Neutral” Rating Restated By Espirito Santo Investment Bank Research – GBX 309 Target Price

June 04 2014

CBOE “Underperform” Rating Restated By Credit Suisse – $49.00 Price Objective

Betfair “Add” Rating Restated By Numis Securities –  GBX 1,150 Price Objective

June 03 2014

LSE‘s “Outperform” Rating Reaffirmed By RBC Capital – GBX 2,200 ($36.88) Target Price

Zacks Restated Their Neutral Rating Of Charles Schwab – $27.00 Target Price

May 27 2014 

LSE “Sell” Rating Reaffirmed By Goldman Sachs – GBX 1,990 Target Price

Tullett Prebon “Neutral” Rating Reiterated By Goldman Sachs – GBX 360 Target Price

May 20 2014

Argus Cut Their Price Target On ICE From $240.00 To $220.00 – “Buy” Rating

May 19 2014

Betfair “Neutral” Rating Reiterated By Credit Suisse – GBX 1,085 Target Price

May 13 2014

Citigroup Reissued Their Hold Rating On ICE – $210.00 Target Price

Raymond James Reissued Their “Outperform” Rating On ICE – $225.00 Target Price

CME Price Target Lowered By Jefferies Group From $89.00 To $84.00 – Buy Rating
LSE “Neutral” Rating Reiterated By HSBC – GBX 2,000 Price Objective
RBC Capital Boosted Their Target Price On TMX From C$55.00 To C$58.00 – “Underperform” Rating
National Bank Financial Raised Their Price Objective On TMX From C$56.00 To C$60.00
Tullett Prebon “Hold” Rating Restated By Societe Generale – GBX 305 Price Objective
Tullett Prebon “Neutral” Rating Reaffirmed By Espirito Santo Investment Bank Research – GBX 337 Price Objective
UBS AG Dropped Their Price Target On Tullett Prebon From GBX 290 To GBX 265 “Sell” Rating

May 07 2014

Charles Schwab Upgraded By Credit Suisse From “Neutral” To “Outperform”

May 06 2014

Goldman Sachs Restated Their “Neutral” Rating On ICAP – GBX 440 Price Target

Zacks Reaffirmed Their “Neutral” Rating On CME – $74.00 Price Objective

CME Target Price Trimmed By Keefe, Bruyette & Woods From $84.00 To $80.00

May 05 2014

LSE “Sell” Rating Reaffirmed By Goldman Sachs GBX 1,700 price target

Tullett Prebon “Neutral” Rating Restated By Goldman Sachs – GBX 390  Target Price

ITG‘s “Overweight” Rating Reaffirmed By JPMorgan Chase – $24.00 Target Price

CIBC Raised Their Price Objective On TMX From C$50.00 To C$55.00 –  “Sector Perform” Rating

CME “Equal Weight” Rating Restated By Barclays –  $78.00 Target Price

Keefe, Bruyette & Woods Raised Their Price Objective On Shares Of ITG From $21.00 To $22.00

April 30 2014

ITG Upgraded By TheStreet Ratings From Hold To Buy

April 28 2014

RBC Capital Increased Price Objective On TMX From C$50.00 To C$55.00 – “Underperform” Rating

April 25 2014

CBOE “Neutral” Rating Reiterated By Zacks – $55.00 Price Objective

April 23 2014

Credit Suisse Upgraded The Rating On NASDAQ OMX From Neutral To Outperform – Price Target Raised From $40.00 To $42.00.

ICE “Overweight” Rating Restated By JPMorgan – $253.50 Price Target

April 22 2014

Charles Schwab Price Objective Raised By Compass Point From $25.00 To $28.00

April 16 2014

Goldman Sachs Restated Their “Neutral” Rating On Tullett Prebon – GBX 390 Target Price

April 15 2014

EVA Dimensions Upgraded ICE From “Sell” To “Underweight”
LSE “Sell” Rating Restated By Goldman Sachs – GBX 1,610 Price Objective
Betfair Target Price Lowered By JPMorgan From GBX 1,100 To GBX 1,050
ICAP “Neutral” Rating Restated By Goldman Sachs – GBX 440 Price Target

April 11 2014

ICE “Neutral” Rating Reaffirmed By Citigroup – $218.00 Price Target
ICE “Buy” Rating Restated By Bank of America – $240.00 Price Objective

April 10 2014

NASDAQ OMX Downgraded By Bank of America From “Buy” To “Neutral”
CBOE Upgraded By Bank of America From “Neutral” To “Buy”
TMX Upgraded By National Bank Financial From “Underperform” To “Sector Perform” – C$56.00 Price Target
Citigroup Lowered Their Price Target On Charles Schwab From $28.00 To $27.00

April 09 2014

Barclays Cut Their Price Target On ICE From $239.00 To $234.00 – “Overweight” Rating
Credit Suisse Upped Their Target Price On NASDAQ OMX From $35.00 To $40.00
LSE “Hold” Rating Restated By Morningstar – GBX 1,700 Target Price
Zacks Upgraded GFI Group From “Underperform” To “Neutral” – $3.60 Price Objective

April 03 2014

Barclays Decreased Their Target Price On CBOE From $50.00 To $49.00 – “Equal Weight” Rating
CME “Neutral” Rating Restated By Zacks – $76.00 Price Target

 

April 02 2014

CME Price Objective Trimmed By Keefe, Bruyette & Woods From $87.00 To $84.00
ICAP “Sell” Rating Reiterated By Canaccord Genuity – GBX 300 Price Objective
Tullett Prebon “Buy” Rating Reiterated By Canaccord Genuity
Sterne Agee Lifted Their Price Objective On Charles Schwab From $27.00 To $30.00

April 01 2014

LSE Price Target Increased By Numis Securities From GBX 1,690 To GBX 1,881

March 28 2014

LSE “Outperform” Rating Restated By RBC Capital

March 27 2014

Nomura Hoisted Their Target Price On Charles Schwab From $24.00 To $26.00
Goldman Sachs Upped Their Price Objective On Betfair From GBX 1,260 to GBX 1,290 – “Buy” Rating

March 25 2014

JPMorgan Chase Lifted Their Price Target On ICAP From GBX 364 To GBX 379 – “Neutral” Rating

March 24 2014

Credit Suisse Upped Their Price Target On LSE From GBX 2,000 To GBX 2,220 – “Outperform” Rating

March 21 2014

TheStreet Upgraded ICE To “Buy”
LSE Upgraded By JPMorgan Chase To “Neutral” – GBX 1,962 Price Objective
Betfair “Neutral” Rating Reaffirmed By Credit Suisse – GBX 1,085 Price Objective
ICAP Price Objective Lowered By Credit Suisse From GBX 415 To GBX 395 – Underperform Rating

March 20 2014

Scotiabank Lifted Their Price Target On TMX From C$52.00 To C$59.00 – “Sector Perform” Rating

March 14 2014

ICAP “Sell” Rating Restated By Espirito Santo Investment Bank Research – GBX 335 Price Objective

March 11 2014

Betfair Price Objective Hosited By JPMorgan Chase From GBX 990 To GBX 1,100 – Neutral Rating

March 10 2014

Deutsche Bank Upped Their Target Price On Betfair From GBX 1,060 To GBX 1,160 – “Hold” Rating
Espirito Santo Investment Bank Research Lowered Tullett Prebon To “Neutral” – GBX 337 Price Objective

March 07 2014

Jefferies Reiterated A “Buy” And $265 Price Target On ICE
CME “Neutral” Rating Restated By Credit Suisse – $70.00 Price Objective
Betfair Downgraded By Numis Securities To “Add” – GBX 1,300 Price Target
Tullett Prebon “Equal Weight” Rating Reaffirmed By Barclays – GBX 335 Price Objective
Tullett Prebon Downgraded By Numis Securities To “Reduce” – GBX 299 Target Price

March 06 2014

Charles Schwab “Neutral” Rating Reiterated By Zacks – $28.00 Target Price

March 05 2014

Credit Suisse Raised Their Price Target On CBOE From $48.00 To $50.00
CME Upgraded By Argus From “Hold” To “Buy” – $84.00 Price Target
Tullett Prebon “Buy” Rating Reiterated By Societe Generale – GBX 310 Price Target

March 04 2014

ICE Upgraded By Thomson Reuters/Verus From “Sell” To “Hold”
Betfair “Neutral” Rating Reaffirmed At Davy Research
Charles Schwab Upgraded By Thomson Reuters/Verus From “Sell” To “Hold”
GFI Group Upgraded By Thomson Reuters/Verus From “Sell” To “Hold”

February 25 2014

Betfair “Buy” Rating Reiterated At Numis Securities – GBX 1,300 Price Target
Zacks Reaffirmed Their “Neutral” Rating On Interactive Brokers – $23.00 Price Target

February 24 2014

CBOE Upgraded At McLean Capital Management From “Neutral” To “Buy”

February 20 2014

LSE “Outperform” Rating Reiterated At Credit Suisse – GBX 2,000 Price Target
ICAP “Overweight” Rating Reiterated At Barclays
Barclays Upped Their Price Target Of Tullett Prebon From GBX 325 To GBX 350 – “Equal Weight” Rating

February 18 2014

GFI Group Downgraded By Zacks From “Neutral” To “Underperform” – $3.70 Price Target

February 14 2014

ICE Downgraded By TheStreet From “Buy” To “Hold”
BMO Capital Markets Lowered Their Price Target On Charles Schwab To $29.00- “Outperform” Rating

February 13 2014

ICE “Neutral” Rating Restated By Zacks – $227.00 Target Price
UBS AG Raised Price Objective On ICE From $235.00 To $251.00 in – “Buy” Rating
BMO Capital Markets Lifted Price Target On ICE To $230.00 “Outperform” Rating
CME Upgraded At TheStreet From “Hold” To “Buy”

February 12 2014

CIBC Lifted Their Price Target On TMX From C$48.00 To C$50.00 – “Market Weight” Rating
Goldman Sachs Upgraded Its Rating For ICAP From ‘Sell’ To ‘Neutral’

February 11 2014

CBOE “Neutral” Rating Restated By Zacks – $56.00 Price Objective
CBOE Target Price Lifted By Credit Suisse From $42.00 To $48.00
CBOE “Market Perform” Rating Reiterated At BMO Capital Markets
CBOE “Neutral” Rating Restated At Bank of America $55.00 Price Objective
Zacks Reissued Neutral Rating On NASDAQ OMX – $40.00 Price Target

February 10 2014

TMX Price Objective Hosited By RBC Capital From C$46.00 To C$50.00 – Underperform Rating
ICAP “Hold” Rating Restated At Societe Generale – GBX 375 Target Price

February 07 2014

JP Morgan Cazenove retains neutral on ICAP, target raised from 344p to 364p
CME “Neutral” Rating Reaffirmed by Zacks – $77.00 Price Target

February 04 2014

NBF Raised Their Target Price On TMX from C$48.00 To C$49.00

January 31 2014

ICAP “Sell” Rating Restated At Espirito Santo Investment Bank – GBX 335 Target Price

January 30 2014

Interactive Brokers Upgraded By Keefe, Bruyette & Woods From “Market Perform” To “Outperform”
LSE “Outperform” Rating Reiterated At Credit Suisse – GBX 2,000 ($32.95) Price Target

January 29 2014

UBS AG Lifted Their Target Price On ICAP from GBX 330 ($5.44) To GBX 340 ($5.60) – “Sell” Rating

January 28 2014

LSE Target Price Lifted By JPMorgan Chase From GBX 1,539 To GBX 1,622
Barclays Reiterated Their “Overweight” Rating On LSE – GBX 2,200 ($36.25) Price Objective
Numis Reiterates “Hold” On LSE, Target Raised From 1477p To 1690p
Betfair Price Target Upped By JPMorgan Chase From GBX 975 To GBX 990

January 27 2014

Betfair “Sell” Rating Reaffirmed By Investec – GBX 950 Price Objective
TD Securities Increased Their Price Target On TMX From C$48.00 To C$53.00 – “Hold” Rating
TheStreet Downgraded Shares Of Interactive Brokers From “Buy” To “Hold”

January 21 2014

Credit Suisse Upped Their Target Price Of LSE from GBX 1,780 To GBX 2,000 – “Outperform” Rating
ICAP Downgraded At HSBC To “Underweight” – GBX 410 Target Price

January 20 2014

ICE “Neutral” Rating Restated by Zacks – $220.00 Target Price
Keefe, Bruyette & Woods Boosted Their Price Objective On Charles Schwab From $26.00 To $29.00
Charles Schwab “Neutral” Rating Reiterated By Zacks – $28.00 Target Price

January 17 2014

Betfair “Hold” Rating Restated At Deutsche Bank – GBX 1,060 Target Price

January 16 2014

LSE “Outperform” Rating Reaffirmed At RBC Capital
Charles Schwab Downgraded At Credit Agricole To “Underperform”

January 14 2014

Credit Suisse Cut Their Price Target On Betfair From GBX 1,185 To GBX 1,085 – “Neutral” Rating
Tullett Prebon Downgraded At Goldman Sachs To “Neutral” – Currently GBX 430 price objective, Up From Previous Price Objective Of GBX 410
ICAP Downgraded At Goldman Sachs To “Sell” – Currently GBX 440 Price Objective Up From GBX 400

January 10 2014

Keefe, Bruyette & Woods Raised Price Objective On Interactive Brokers From $23.00 To $24.00
Nomura Began Coverage On Charles Schwab – “Neutral” Rating And $23.00 Price Target

January 09 2014

NASDAQ OMX Upgraded At Citigroup From “Neutral” To “Buy”
CME Downgraded At Citigroup From “Buy” To “Neutral”
Citigroup Began Coverage On ICE – “Neutral” Rating

January 08 2014

Charles Schwab Downgraded At Citigroup From “Buy” To “Neutral”
LSE “Buy” Rating Restated At Espirito Santo Investment Bank Research – GBX 1,990.50 Price Target

January 06 2014

LSE‘s “Overweight” Rating Restated At Barclays – GBX 1,800 Target Price
ICAP’s “Overweight” Rating Reiterated At Barclays – GBX 455 Price Target
Tullett Prebon’s “Equal Weight” Rating Reiterated At Barclays – GBX 325 Target Price

January 03 2013

Zacks Upgraded ITG From “Neutral” To “Outperform” – $21.80 Price Target

December 23 2013

JPMorgan Chase & Co. Assumed Coverage On NASDAQ OMX – “Neutral” Rating And $44.50 Price Target

December 19 2013

Investec Increased The Price Target On Betfair From GBX 750 To GBX 950 – “Sell” Rating
Charles Schwab Upgraded By Evercore Partners From “Underweight” To “Equal Weight”

December 13 2013

Charles Schwab Upgraded By Keefe, Bruyette & Woods To “Market Perform” Rating

December 11 2013

Credit Suisse Initiated Coverage On CBOE – “Underperform” Rating
Credit Suisse Started Coverage On NASDAQ OMX – “Neutral” Rating
Credit Suisse Initiated Coverage On Charles Schwab – “Neutral” Rating
LSEG “Overweight” Rating Restated At Barclays – GBX 1,800 Price Objective

December 10 2013

LSE “Neutral” Rating Reiterated At HSBC – GBX 1,710 target price

December 06 2013

NASDAQ OMX “Neutral” Rating Restated By Zacks – $42.00 Price Target
J.P. Morgan Reiterated An “Overweight” Rating On ICE And Raised Price Target From $235.00 To $242.00.
ICAP “Underperform” Rating Reaffirmed At Credit Suisse – GBX 350 Target Price
Jefferies Group Reissued Their “Buy” Rating On Betfair – GBX 1,175 Price Objective
Deutsche Bank Hoisted Their Target Price On Betfair From GBX 945 To GBX 1,060 – “Hold” Rating

December 04 2013

LSE “Outperform” Rating Reiterated At RBC Capital

December 02 2013

Charles Schwab “Neutral” Rating Restated By Zacks – $26.00 Price Target
Betfair “Buy” Rating Restated At Panmure Gordon – GBX 1,317 Target Price

November 29 2013

Credit Suisse Reissued Their “Outperform” Rating On Betfair – GBX 1,185 Price Objective
Betfair “Buy” Rating Reiterated By Numis Securities – GBX 1,200 Price Objective

November 28 2013

NASDAQ OMX “Neutral” Rating Reiterated At Citigroup – $40.00 Price Target

November 27 2013

Argus Lifted Their Price Objective On ICE From $195.00 To $240.00 – “Buy” Rating
ICAP Target Price Boosted By Barclays From GBX 450 To GBX 455 – ”Overweight” Rating

November 26 2013

LSE “Buy” Rating Reiterated At Galvan Research – GBX 1,700 Price Target

November 25 2013

Goldman Sachs Lifted Their Price Target on LSEG From GBX 1,250 To GBX 1,310 – “Sell” Rating

November 21 2013

Jefferies Group Reiterated A “Buy” Rating On ICE, Raised The Price Target From $215.00 To $235.00
Interactive Brokers “Neutral” Rating Reaffirmed By Zacks – $25.00 Target Price

November 20 2013

Espirito Santo Investment Bank Cut Their Price Objective On Tullett Prebon From GBX 364 To GBX 354 – “Buy” Rating

November 19 2013

CME Price Target Upped By BMO Capital Markets – “Outperform” Rating
CME Downgraded By Zacks From “Outperform” To A “Neutral” Rating – $84.00 Price Target
ICE Upgraded By JPMorgan Chase & Co From A “Neutral” To An “Overweight” Rating
ICE Upgraded At BMO Capital Markets To “Outperform”
Charles Schwab Target Price Lifted By Barclays From $18.00 To $19.00 – “Underweight” Rating
Interactive Brokers Group was downgraded At Keefe, Bruyette & Woods From An “Outperform” To A “Market Perform” Rating

November 18 2013

Charles Schwab “Sell” Rating Restated At Keefe, Bruyette & Woods – $20.00 Price Objective

November 15 2013

Numis Securities Dropped Their Price Objective On LSE From GBX 1,505 To GBX 1,477 – “Hold” Rating
LSE‘s Had Its “Neutral” Rating Reaffirmed At UBS AG – GBX 1,550 Price Objective

November 14 2013

LSE “Buy” Rating Reaffirmed at Espirito Santo Investment Bank Research – GBX 1,718 Price Objective

November 13 2013

Jefferies Group Boosted Their Price Target On NASDAQ OMX From $32.00 To $35.00 – “Hold” Rating
Tullett Prebon “Hold” Rating Restated At Numis Securities Ltd – GBX 299 Price Target

November 12 2013

Credit Suisse Reiterated Their “Outperform” Rating on LSE – GBX 1,700 Price Objective
UBS AG Decreased Their Price Objective On Tullett Prebon From GBX 315 To GBX 290 – “Sell” Rating
Betfair “Hold” Rating Reiterated At Deutsche Bank – GBX 945 Price Objective

November 11 2013

HSBC Initiated Coverage On Betfair – “Overweight” Rating And GBX 1,245 Price Target
CIBC Hoisted Their Target Price On Shares Of TMX From C$46.00 To C$48.00 “Sector Perform” Rating

November 08 2013

CME Price Objective Hosited By Barclays From $68.00 To $78.00 – “Equal Weight” Rating.

November 07 2013

ICE “Neutral” Rating Restated By Zacks – $208.00 Target Price

RBC Capital Markets Reiterates “Outperform” on LSE, Target Raised From 1600 To 1800 GBX

November 05 2013

Credit Suisse Lifted Their Target Price On CME From $65.00 To $70.00 – “Neutral” Rating
CME “Buy” Rating Reiterated At Keefe, Bruyette & Woods – $89.00 Price Objective
Keefe, Bruyette & Woods Raised Their Price Target On CBOE From $51.00 To $55.00
CBOE “Hold” Rating Reaffirmed At JPMorgan Chase & Co. – $48.00 Price Objective
CBOE Price Target Increased By Barclays From $42.00 To $48.00 – “Equal Weight” Rating

October 31 2013

Credit Suisse Began Coverage On Betfair – “Outperform” Rating – GBX 1,185 Price Target

October 30 2013

CBOE Holdings Upgraded At Macquarie To “Outperform” Rating

October 28 2013

NASDAQ OMX “Neutral” Rating Reaffirmed By Zacks – $37.00 Target Price

October 25 2013

BMO Capital Markets Raised Their Target Price On NASDAQ OMX From $37.00 To $38.00 – “Outperform” Rating
Sandler O’Neill Raised Their Price Objective On NASDAQ OMX From $35.00 To $39.00 – “Buy” Rating
JPMorgan Chase & Co. Upped Their Price Objective On CME from $72.00 to $75.50 – “Neutral” Rating
JPMorgan Chase & Co. Raised Their Price Target On Investment Technology Group From $17.00 To $20.00 – “Overweight” Rating

October 24 2013

Compass Point Hoisted Their Target Price Of CME From $70.00 To $75.00 – “Neutral” Rating
JPMorgan Chase & Co. Raised Their Price Target On CBOE From $41.50 To $48.00 – “Neutral” Rating
Credit Suisse Upped Their Target Price On NASDAQ OMX From $33.00 To $35.00 – “Neutral” Rating

October 23 2013

JPMorgan Chase & Co. Increased Their Price Objective On Betfair From GBX 825 To GBX 1,000 – “Neutral” Rating

October 21 2013

CBOE Upgraded At UBS AG From “Neutral” To “Buy” Rating

October 18 2013

CBOE “Hold” Rating Restated At Jefferies Group – $51.00 Price Target
LSE “Reduce” Rating Reiterated at AlphaValue – GBX 1,490 Price Target
Keefe, Bruyette & Woods Increased Price Target On Charles Schwab From $18.00 To $20.00 – “Underperform” Rating
BMO Capital Markets Raised Price Target On Charles Schwab From $24.00 To $26.00 – “Outperform” Rating
Sandler O’Neill Raised Price Target on Interactive Brokers From $21.00 To $22.00

October 17 2013

Compass Point Dropped Their Price Objective On CBOE From $50.00 To $45.00 “Neutral” Rating
National Bank Financial Lowered Their Price Objective On TMX From C$47.00 To C$44.00
Credit Suisse Lifted Their Price Objective On Shares Of Charles Schwab From $19.00 To $20.00 – “Neutral” Rating
Compass Point Upgraded The Rating On Charles Schwab From “Sell” to “Neutral”, And Raised The Price Target From $17.00 To $20.00

October 14 2013

NASDAQ OMX Target Price Trimmed By Keefe, Bruyette & Woods From $37.00 To $36.00 – “Market Perform” Rating

October 11 2013

Tullett Prebon “Neutral” Rating Restated by Macquarie – GBX 323 Target Price
Keefe, Bruyette & Woods raised their price target on Interactive Brokers from $21.00 to $23.00 – “Outperform” Rating

October 10 2013

JMP Securities Assumed Coverage On Charles Schwab – “Market Perform” Rating

October 07 2013

ICE “Neutral” Rating Reiterated By Zacks – $193.00 Target Price

October 04 2013

LSE “Reduce” Rating Reaffirmed At AlphaValue – GBX 1,478 Price Target

October 03 2013

Betfair Group “Buy” Rating Restated At Citigroup Inc. – GBX 1,150 Price Target
Tullett Prebon“buy” Rating Reiterated At Goldman Sachs Group Inc. GBX 410 Price Target

September 30 2013

JPMorgan Chase & Co. increased their price target on LSE from GBX 1,406 to GBX 1,539 – “Underweight” rating.

September 27 2013

NYSE Euronext “Neutral” rating reiterated by Zacks – $44.00 price objective

September 26 2013

CME upgraded at Keefe, Bruyette & Woods from a “Market Perform” to “Outperform” rating – $89.00 target price (from $81.00).

LSE “Buy” rating reaffirmed at Espirito Santo Investment Bank Research – GBX 1,718 price target

September 25 2013

NASDAQ OMX Group Given “Neutral” Rating at Zacks – $34.00 target price

September 24 2013

London SE – Upgraded at AlphaValue to a “Reduce” Rating – GBX 1,474.70 Price Target

September 20 2013

Stifel Nicolaus lifted their target price on ICE from $185.00 to $195.00 – “Buy”

ICE “Buy” rating reiterated at UBS AG – $215.00 price objective

September 17 2013

London Stock Exchange Group Plc’s “Outperform” Rating Reaffirmed at RBC Capital

September 13 2013

Jefferies Group Target Price On Betfair Group From GBX 930 To GBX 1,175 – “Buy” Rating

September 12 2013

ITG downgraded at Keefe, Bruyette & Woods from an “Outperform” to a “Market Perform” Rating

September 11 2013

Betfair Group Price Target Increased from GBX 884 to GBX 945 by Analysts at Deutsche Bank – “Hold” Rating

E TRADE Financial Upgraded To “Outperform” At Macquarie – $21.00 Price Target

September 09 2013

NASDAQ OMX Group Price Target Cut from $39.00 to $38.00 by Barclays Capital – “Overweight” Rating

September 06 2013

Numis Reiterates “Buy” on Betfair, Target Raised From 1100p To 1200p

September 05 2013

Charles Schwab “Neutral” rating reaffirmed by Zacks- $22.00 price objective

September 04 2013

Jefferies Reiterated A “Buy” Rating And $86 Price Target On CME Group
BMO Capital Markets Started Coverage On Shares Of CME Group Setting An “Outperform” Rating
NASDAQ OMX Group Was Upgraded At BMO Capital Markets From A “Market Perform” To An “Outperform” Rating – $37.00 Target Price.
London Stock Exchange Group “Outperform” Rating Restated At RBC Capital
GFI Group Upgraded at BMO Capital Markets From A “Market Perform” To An “Outperform” Rating

September 03 2013

Betfair Group had its “Buy” rating reiterated at Panmure Gordon – GBX 1,317 target price.

August 28 2013

Wells Fargo initiated coverage on IntercontinentalExchange with an “Outperform” rating – $210-$230

August 26 2013

ICE’s “Buy” Rating Reaffirmed at UBS AG – $215.00 Price Target
Betfair Group’s “Overweight” Rating Reiterated by Morgan Stanley – GBX 1,000 Price Target.
Interactive Brokers Group‘s “Neutral” Rating Reaffirmed by Zacks – $18.00 Price Target

August 23 2013

ICE Price Target Increased to $200.00 by Analysts at Bank of America Corp. – “Buy” Rating

August 22 2013

NASDAQ OMX Rating Upgraded by Raymond James from “Outperform” to “Strong-Buy” – $38 Price Target

August 15 2013

CME was upgraded by Zacks from a “Neutral” to an “Outperform” rating – $89.00 price objective

August 14 2013

LSE Group’s “Overweight” Rating Reaffirmed at Barclays Capital – GBX 1,800 target price

August 09 2013

Tullett Prebon Price Target Raised from GBX 300 to GBX 340 at Citigroup Inc. – “Neutral” rating

August 08 2013

CBOE Holdings Price Target Cut from $43.00 to $42.00 by Analysts at Barclays Capital

UBS lifted its price target on “Buy”-rated ICE from $193 to $215

ICE’s “Neutral” Rating Reaffirmed at Zacks – $196.00 price target

August 07 2013

CBOE Holdings price target raised from $35.00 to $42.00 at Credit Suisse

August 06 2013

Goldman Sachs Downgrades CBOE from “Buy” to “Neutral” – $49.00 price target

Betfair “Buy” rating restated by equities researchers at Citigroup Inc. – GBX 975 target price

August 05 2013

UBS AG Reiterates “Buy” Rating for CME Group – $83.00 price target

Betfair Group’s “Overweight” Rating Reaffirmed at Morgan Stanley – GBX 1,000 ($15.38) price objective

Compass Point upped their price target on shares of CBOE Holdings from $42.00 to $50.00 – “Neutral” rating

August 02 2013

NYSE Euronext Receives “Neutral” Rating from Zacks

Tullett Prebon Receives “Hold” Rating from Numis Securities Ltd – GBX 294 price objective

August 01 2013

NYSE Euronext (NYSE:NYX)‘s stock had its “Neutral” rating reiterated by Zacks – $44.00 price target

Tullett Prebon rating lowered to “Neutral” at HSBC – GBP 375 target

July 31 2013

Goldman Sachs downgraded NASDAQ OMX Group from “Neutral” to “Sell”, and lowered the price target from $30.00 to $28.00.

Compass Point increased their target price on shares of NASDAQ OMX Group from $30.00 to $33.00 – “Neutral” rating

GFI Group was upgraded by Zacks from a “Neutral” rating to an “Outperform” rating – $4.60 target price

Credit Suisse hoisted their price target on shares of Charles Schwab Corp from $17.00 to $19.00 – “Neutral” rating

July 30 2013

LSE Rating Reaffirmed “Outperform” rating by Credit Suisse

NASDAQ OMX Price Target Increased to $33.00 by Credit Suisse: “Neutral” rating

BMO Capital Markets Increases Charles Schwab Price Target to $24.00, reiterates “Outperform” rating.

Numis Securities Ltd reaffirmed “Buy” rating on Betfair

July 29 2013

Citigroup Inc. raised CME target price to $82.00

Betfair stock rating reaffirmed “buy” by Societe Generale

ME stock reaffirmed “hold” by Keefe, Bruyette & Woods

July 26 2013

Morgan Stanley Increases LSE Price Target to GBX 1,705 reiterates “overweight” rating.

July 24 2013

London Stock Exchange Group Plc’s “Overweight” Rating Reaffirmed at Barclays Capital

July 23 2013

National Bank Financial Downgrades TMX Group to “Underperform”

Citigroup reiterated “Neutral” rating on NASDAQ OMX

Bank of America raised LSE to 16.00 GBP reiterates “neutral” rating on the stock.

Espirito Santo restated “buy” rating on LSE

NASDAQ OMX Group Receives “Neutral” Rating from Citigroup Inc

July 22 2013

Charles Schwab rated “Neutral” by JPMorgan

Charles Schwab Given New $17.00 Price Target at Compass Point, reiterates “sell” rating.

Charles Schwab Receives “Hold” Rating from Goldman Sachs

Charles Schwab Given Buy Rating at ISI Group

Zacks Reiterates “Neutral” Rating for Charles Schwab Corp.

TMX Price Target Lowered to C$51.00 by Scotiabank, reiterates “sector perform” rating.

Barclays Capital Reiterates “Equal Weight” Rating for Tullett Prebon

Betfair “overweight” rating reiterated by investment analysts at Morgan Stanley

LSE Receives “Hold” Rating from Charles Stanley

CME Coverage initiated by Argus with “hold” rating.

July 19 2013

Keefe, Bruyette & Woods Increases CBOE Holdings Price Target to $51.00 (CBOE) maintains market perform.

NASDAQ OMX Group (NASDAQ: NDAQ) target price lifted by Keefe, Bruyette & Woods from $32.00 to $37.00 Reiterate “market perform” rating.

Interactive Brokers(Nasdaq:IBKR) upgraded by TheStreet Ratings from hold to buy.

Interactive Brokers Group Price Target Raised to $20.00 at Keefe, Bruyette & Woods reiterate “outperform” rating.

July 18 2013

Goldman Sachs Group Inc. Reiterates “Buy” Rating for CBOE Holdings

CBOE Holdings Given New $42.00 Price Target at Compass Point, reiterates “neutral” rating

Goldman Sachs alters recommendation on Tullett Prebon to “buy” from “conviction buy”

Analysts at UBS AG raised their target price on shares of Charles Schwab reiterating their “neutral” rating.

July 17 2013

Macquarie reaffirmed their “neutral” rating on shares of NYSE Euronext

ICE Given $225.00 Price Target at eefe, Bruyette & Woods

NASDAQ OMX Group Given neutral rating by Compass Point

CME given a “market perform” rating on the stock by Keefe, Bruyette & Woods

NYSE Euronext was upgraded by Keefe, Bruyette & Woods from “market perform” to “outperform”

July 16 2013

Macquarie reissued their outperform rating on shares of NASDAQ OMX Group

July 15 2013

IntercontinentalExchange Given “Outperform” Rating at Macquarie

Intercontinental Exchange “Buy” Rating Reiterated by TheStreet

Tullett Prebon Downgraded by UBS AG to “Sell”

July 12 2013

IntercontinentalExchange Given “Outperform” Rating at Macquarie

IntercontinentalExchange “Buy” Rating Reiterated by TheStreet

Tullett Prebon Downgraded by UBS AG to “Sell”

July 11 2013

NASDAQ OMX EPS Estimates Cut by Credit Suisse – “Neutral” rating

IntercontinentalExchange reiterated by TheStreet Ratings as a “Buy”

July 10 2013

Charles Schwab Corp. stock “Buy” rating reaffirmed by equities researchers at BMO Capital Markets

Keefe, Bruyette & Woods lifted price objective on shares of Charles Schwab Corp to $18.00 – “Underperform” rating

Charles Schwab Corp. Given “Buy” Rating at TheStreet

July 09 2013

Zacks Downgrades CBOE Holdings to “Neutral”

JP Morgan Cazenove reissued their “Neutral” rating on Betfair Group

TD Securities dropped their price objective on shares of TMX Group from C$47.00 to C$45.00 – “Reduce” rating

July 08 2013

ICAP plc Upgraded to “Neutral” at Espirito Santo Investment Bank Research

London Stock Exchange Group Plc’s “Overweight” Rating Reaffirmed at Morgan Stanley

Nasdaq OMX Group Inc Upgraded to “Neutral” by Zacks Investment Research

July 05 2013

NASDAQ OMX Group’s Buy Rating Reaffirmed at Macquarie (NDAQ) -$37.00 price objective

July 04 2013

CME Group Given a $86.00 Price Target at Jefferies Group – “Buy” rating

Credit Suisse Increases CME Group Price Target to $65.00 – “Neutral” rating

CBOE Holdings PT Raised to $44.00 at Keefe, Bruyette & Woods – “Market Perform” rating

CBOE Holdings Price Target Increased to $35.00 by Analysts at Credit Suisse – “Underperform” rating

CBOE Holdings Price Target Raised to $48.00 at Sandler O’Neill – “Hold” rating

CBOE Holdings’s “Buy” Rating Reaffirmed at Goldman Sachs – $47.00 target price

Jefferies Group lifted their target price on shares of CBOE Holdings to $47.00 – “Hold” rating

NYSE Euronext Given a $42.00 Price Target at Jefferies Group

NASDAQ OMX Group Price Target Raised to $32.00 at Jefferies Group – “Hold” rating

July 03 2013

Credit Suisse Boosts Price Target, Estimates on CBOE Holdings; Maintains “Underperform” Rating

CME Group Downgraded at Raymond James

Betfair Group Price Target Increased to GBX 975 by Analysts at Citigroup – “Buy” rating currently

July 02 2013

Betfair Group Given “Hold” Rating at Deutsche Bank

Analysts at Nomura reiterated a “Neutral” rating on shares of Betfair Group

Numis Securities Ltd restated their “Buy” rating on shares of Betfair Group

Citigroup reiterates “Buy” on Betfair, target raised from 950p to 975p

TMX Group had its price objective lowered by Scotiabank from C$55.00 to C$53.00, “Sector Perform” rating

June 28 2013

IntercontinentalExchange “Buy” rating reaffirmed by stock analysts at TheStreet

CME Group Upgraded to “Market Perform” by JP Morgan Cazenove

Charles Schwab Corp. Given “Buy” Rating at TheStreet

June 27 2013

Betfair Group Given “Outperform” Rating at BNP Paribas (BET)

CBOE Holdings Upgraded to Strong Buy at Zacks Investment Research

TMX Group Price Target Cut to C$46.00 by Analysts at National Bank Financial

“Overweight” rating on Nasdaq OMX Group at Barclays Capital

June 26 2013

CME Group Upgraded To “Neutral” By JPMorgan

CME Group Given New $85.00 Price Target at Sandler O’Neill

June 25 2013

Goldman Sachs Upgrades CBOE Holdings To “Buy”

Goldman Sachs Upgrades CME Group Rating To “Neutral”

Goldman Sachs Gives Bolsas y Mercados Espanoles, “Hold” Rating

Goldman Sachs Gives NASDAQ OMX Group “Neutral” Rating

Citigroup Increases Charles Schwab Corp. Rating To “Buy”

JP Morgan Cazenove Cuts Betfair Group Price Target To GBP 8.25

November 2017
M T W T F S S
« Jul    
 12345
6789101112
13141516171819
20212223242526
27282930